Read + Share
Panaccione R, Danese S, Sandborn WJ, O'Brien CD, et al. Ustekinumab is effective and safe for ulcerative colitis through 2 years of
maintenance therapy. Aliment Pharmacol Ther 2020 Oct 21. doi: 10.1111/apt.16119.
PMID: 33086438
|
 |
|
Panaccione R, Danese S, Sandborn WJ, O'Brien CD, et al. Ustekinumab is effective and safe for ulcerative colitis through 2 years of
maintenance therapy. Aliment Pharmacol Ther 2020 Oct 21. doi: 10.1111/apt.16119.
PMID: 33086438
|
|
|
|